1-Methylpsilocin
http://dbpedia.org/resource/1-Methylpsilocin an entity of type: Thing
1-Methylpsilocin is a tryptamine derivative which acts as a selective agonist for the 5-HT2C receptor (IC50 of 12 nM, vs 633 nM at 5-HT2A), and an inverse agonist at 5-HT2B (Ki of 38 nM). While 1-methylpsilocin does have higher affinity for 5-HT2C than 5-HT2A, it does produce a head-twitch response in mice that are dependent on 5-HT2A, so it is not entirely free of effects on 5-HT2A in vivo. In contrast to psilocin, 1-methylpsilocin did not activate 5-HT1A receptors in mice. 1-Methylpsilocin has been investigated for applications such as treatment of glaucoma, OCD, and cluster headaches, as these conditions are amenable to treatment with psychedelic drugs but are not generally treated with such agents due to the hallucinogenic side effects they produce, which are considered undesirable. 1-
rdf:langString
rdf:langString
1-Methylpsilocin
xsd:integer
44501878
xsd:integer
1086113564
xsd:integer
13
xsd:integer
1465
xsd:integer
197664
xsd:integer
21686519
xsd:integer
18
xsd:integer
1
xsd:integer
2
xsd:integer
1
xsd:integer
44404883
rdf:langString
CNCCcc2c1cccc2O
xsd:integer
1
rdf:langString
MZZRFEIDRWKTKJ-UHFFFAOYSA-N
xsd:integer
3
xsd:integer
65
rdf:langString
1-Methylpsilocin is a tryptamine derivative which acts as a selective agonist for the 5-HT2C receptor (IC50 of 12 nM, vs 633 nM at 5-HT2A), and an inverse agonist at 5-HT2B (Ki of 38 nM). While 1-methylpsilocin does have higher affinity for 5-HT2C than 5-HT2A, it does produce a head-twitch response in mice that are dependent on 5-HT2A, so it is not entirely free of effects on 5-HT2A in vivo. In contrast to psilocin, 1-methylpsilocin did not activate 5-HT1A receptors in mice. 1-Methylpsilocin has been investigated for applications such as treatment of glaucoma, OCD, and cluster headaches, as these conditions are amenable to treatment with psychedelic drugs but are not generally treated with such agents due to the hallucinogenic side effects they produce, which are considered undesirable. 1-Methylpsilocin therefore represents a potential alternative treatment to psilocin that may be less likely to produce hallucinogenic effects.
xsd:nonNegativeInteger
3569
xsd:string
1465-16-3
xsd:string
197664
xsd:string
65MKC68UST
xsd:string
44404883